SILONasdaqPharmaceutical PreparationsFiscal year ends December 31

Silo Pharma, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$1.13−0.05 (-4.24%)

Close on Oct 19, 2026

Market cap: $1.24M
P/E (TTM): –
Dividend yield: –

Dividends

Silo Pharma has not reported a dividend

No dividend per share appears in Silo Pharma's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Silo Pharma's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on Aug 13, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SILO.

Company	Revenue	Growth
ASBP	$97.66K	–
SILO	$54.08K	-25.0%
IXHL	–	–
JUNS	–	–
KPRX	–	–
AVTX	–	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 3
Held by institutions: 9.0%
Auditor: Salberg& Company, P.A.
SEC CIK: 1514183

Advertisement
300 × 250